170 related articles for article (PubMed ID: 33824675)
1. Jian-Gan-Xiao-Zhi Decoction Alleviates Inflammatory Response in Nonalcoholic Fatty Liver Disease Model Rats through Modulating Gut Microbiota.
Liao J; Xie X; Gao J; Zhang Z; Qu F; Cui H; Cao Y; Han X; Zhao J; Wen W; Wang H
Evid Based Complement Alternat Med; 2021; 2021():5522755. PubMed ID: 33824675
[TBL] [Abstract][Full Text] [Related]
2. Mechanical Study of Jian-Gan-Xiao-Zhi Decoction on Nonalcoholic Fatty Liver Disease Based on Integrated Network Pharmacology and Untargeted Metabolomics.
Cao YJ; Li HZ; Zhao J; Sun YM; Jin XW; Lv SQ; Luo JY; Fang XX; Wen WB; Liao JB
Evid Based Complement Alternat Med; 2022; 2022():2264394. PubMed ID: 35845577
[TBL] [Abstract][Full Text] [Related]
3. Intervention of Shugan Xiaozhi Decoction on Nonalcoholic Fatty Liver Disease via Mediating Gut-Liver Axis.
Yang H; Feng L; Xu L; Jiang D; Zhai F; Tong G; Xing Y
Biomed Res Int; 2022; 2022():4801695. PubMed ID: 35837380
[TBL] [Abstract][Full Text] [Related]
4. Er-Chen Decoction Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Rats through Remodeling Gut Microbiota and Regulating the Serum Metabolism.
Miao J; Guo L; Cui H; Wang L; Zhu B; Lei J; Li P; Jia J; Zhang Z
Evid Based Complement Alternat Med; 2022; 2022():6221340. PubMed ID: 35399623
[TBL] [Abstract][Full Text] [Related]
5. [Effect of nuciferine on gut microbiota and inflammatory response in obese model mice].
Xiong WT; Liao JB; Yang ZX; Cui HT; Zhang ZY; Wen WB; Wang HW
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):2104-2111. PubMed ID: 33982526
[TBL] [Abstract][Full Text] [Related]
6. Baihu renshen decoction ameliorates type 2 diabetes mellitus in rats through affecting gut microbiota enhancing gut permeability and inhibiting TLR4/NF-κB-mediated inflammatory response.
Yao B; Pan B; Tian T; Su X; Zhang S; Li H; Li W; Wang Y; Lv S; Zhang Z
Front Cell Infect Microbiol; 2022; 12():1051962. PubMed ID: 36439213
[TBL] [Abstract][Full Text] [Related]
7. Combination of Probiotics and
Wang W; Xu AL; Li ZC; Li Y; Xu SF; Sang HC; Zhi F
Diabetes Metab J; 2020 Apr; 44(2):336-348. PubMed ID: 31950772
[TBL] [Abstract][Full Text] [Related]
8. Assessing the
Wang Y; Wang Z; Wan Y; Jin F; Shi X; Xing Z; Tian B; Li B
Front Nutr; 2023; 10():1147423. PubMed ID: 37020807
[TBL] [Abstract][Full Text] [Related]
9. Yinchen Linggui Zhugan decoction ameliorates high fat diet-induced nonalcoholic fatty liver disease by modulation of SIRT1/Nrf2 signaling pathway and gut microbiota.
Jiang H; Mao T; Sun Z; Shi L; Han X; Zhang Y; Zhang X; Wang J; Hu J; Zhang L; Li J; Han H
Front Microbiol; 2022; 13():1001778. PubMed ID: 36578580
[TBL] [Abstract][Full Text] [Related]
10. Da-Chai-Hu Decoction Ameliorates High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Through Remodeling the Gut Microbiota and Modulating the Serum Metabolism.
Cui H; Li Y; Wang Y; Jin L; Yang L; Wang L; Liao J; Wang H; Peng Y; Zhang Z; Wang H; Liu X
Front Pharmacol; 2020; 11():584090. PubMed ID: 33328987
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.
Tang W; Yao X; Xia F; Yang M; Chen Z; Zhou B; Liu Q
Oxid Med Cell Longev; 2018; 2018():7261619. PubMed ID: 30671174
[TBL] [Abstract][Full Text] [Related]
12. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
[TBL] [Abstract][Full Text] [Related]
13. Acupuncture improved hepatic steatosis in HFD-induced NAFLD rats by regulating intestinal microbiota.
Wang H; Wang Q; Liang C; Pan L; Hu H; Fang H
Front Microbiol; 2023; 14():1131092. PubMed ID: 37007509
[TBL] [Abstract][Full Text] [Related]
14. The Therapeutic Efficacy of Curcumin vs. Metformin in Modulating the Gut Microbiota in NAFLD Rats: A Comparative Study.
Li R; Yao Y; Gao P; Bu S
Front Microbiol; 2020; 11():555293. PubMed ID: 33584555
[TBL] [Abstract][Full Text] [Related]
15. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
Shen SH; Zhong TY; Peng C; Fang J; Lv B
BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
[TBL] [Abstract][Full Text] [Related]
16. Effect of Jiangan-Jiangzhi Pill on Gut Microbiota and Chronic Inflammatory Response in Rats with Non-Alcoholic Fatty Liver.
Zhao Z; Wang J; Ren W; Bian Y; Wang Y; Wang L; Guo L; Lei J; Jia J; Miao J
Chem Biodivers; 2022 May; 19(5):e202100987. PubMed ID: 35324083
[TBL] [Abstract][Full Text] [Related]
17. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
[TBL] [Abstract][Full Text] [Related]
18. Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway.
Luo M; Yan J; Wu L; Wu J; Chen Z; Jiang J; Chen Z; He B
J Immunol Res; 2021; 2021():2264737. PubMed ID: 34458376
[TBL] [Abstract][Full Text] [Related]
19. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier.
Li Y; Liu T; Yan C; Xie R; Guo Z; Wang S; Zhang Y; Li Z; Wang B; Cao H
Mol Pharm; 2018 Sep; 15(9):3860-3870. PubMed ID: 30036479
[TBL] [Abstract][Full Text] [Related]
20. Kang-Xian Pills Inhibit Inflammatory Response and Decrease Gut Permeability to Treat Carbon Tetrachloride-Induced Chronic Hepatic Injury through Modulating Gut Microbiota.
Wang L; Cui H; Li Y; Cao M; Man S; Guo L; Miao J; Jia J; Bian Y; Zhang Z
Evid Based Complement Alternat Med; 2020; 2020():8890182. PubMed ID: 33144872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
